Insider Transactions in Q4 2020 at Tandem Diabetes Care Inc (TNDM)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
Edward L Cahill Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,892
+24.36%
|
-
|
|
Dec 16
2020
|
Kim D Blickenstaff Director |
SELL
Open market or private sale
|
Indirect |
94,600
-3.28%
|
$8,324,800
$88.42 P/Share
|
|
Dec 15
2020
|
Kim D Blickenstaff Director |
SELL
Open market or private sale
|
Indirect |
13,598
-0.9%
|
$1,237,418
$91.74 P/Share
|
|
Dec 11
2020
|
Kim D Blickenstaff Director |
SELL
Open market or private sale
|
Indirect |
9,150
-1.19%
|
$850,950
$93.0 P/Share
|
|
Dec 09
2020
|
Kim D Blickenstaff Director |
SELL
Open market or private sale
|
Indirect |
15,850
-1.01%
|
$1,489,900
$94.64 P/Share
|
|
Dec 08
2020
|
Kim D Blickenstaff Director |
SELL
Bona fide gift
|
Indirect |
39,000
-0.69%
|
$3,549,000
$91.94 P/Share
|
|
Dec 01
2020
|
Rebecca B Robertson Director |
SELL
Open market or private sale
|
Direct |
1,500
-100.0%
|
$141,000
$94.03 P/Share
|
|
Dec 01
2020
|
Rebecca B Robertson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$51,000
$34.0 P/Share
|
|
Dec 01
2020
|
Kim D Blickenstaff Director |
SELL
Open market or private sale
|
Indirect |
25,000
-2.94%
|
$2,425,000
$97.01 P/Share
|
|
Nov 12
2020
|
Kim D Blickenstaff Director |
SELL
Open market or private sale
|
Indirect |
16,802
-0.97%
|
$1,781,012
$106.34 P/Share
|
|
Nov 10
2020
|
Kim D Blickenstaff Director |
SELL
Open market or private sale
|
Indirect |
25,000
-2.8%
|
$2,500,000
$100.09 P/Share
|
|
Nov 10
2020
|
Kim D Blickenstaff Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,048
+0.67%
|
$66,528
$11.06 P/Share
|
|
Nov 09
2020
|
Dick Allen Director |
SELL
Bona fide gift
|
Indirect |
5,000
-8.71%
|
$555,000
$111.33 P/Share
|
|
Nov 09
2020
|
Dick Allen Director |
SELL
Open market or private sale
|
Indirect |
20,432
-15.7%
|
$2,186,224
$107.71 P/Share
|
|
Nov 09
2020
|
Dick Allen Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
20,432
+12.1%
|
$1,348,512
$66.36 P/Share
|
|
Oct 13
2020
|
John F Sheridan PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct |
15,000
-41.27%
|
$1,815,000
$121.52 P/Share
|
|
Oct 13
2020
|
John F Sheridan PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+44.44%
|
$270,000
$18.86 P/Share
|
|
Oct 13
2020
|
Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-31.42%
|
$1,210,000
$121.42 P/Share
|
|
Oct 13
2020
|
Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+40.78%
|
$180,000
$18.86 P/Share
|
|
Oct 13
2020
|
David B Berger EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,000
-52.27%
|
$595,000
$119.25 P/Share
|
|
Oct 13
2020
|
David B Berger EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+34.33%
|
$90,000
$18.86 P/Share
|
|
Oct 07
2020
|
Brian B Hansen EVP & CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-76.28%
|
$1,755,000
$117.76 P/Share
|
|
Oct 07
2020
|
Brian B Hansen EVP & CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+43.27%
|
$765,000
$51.5 P/Share
|